On August 11th Crescita Q2 2020 financials were released. It was a difficult quarter for Crescita. In March Crescita closed its office and manufacturing facility in Quebec. Not only was…
After reviewing Brinks Q1 2020 conference call transcript I realized that Brinks is launching Cirreon Banking under their Brinks Complete solution. Brinks is in the midst of launching Strategy 2.0.…
On May 21st, 2020, CO2 Gro Q1 2020 results were released. We are starting to see revenue come in from the Missouri hemp installations but it is still early days.…
On April 20th, 2020 CO2 Gro 2019 results were released. While revenue did not grow as anticipated the company made significant progress in 2019. A major development for the company…
On April 28th, 2020, RIWI Q1 2020 financials were released. It was a record quarter for RIWI as they earned $1.3 million in revenue. This was accomplished with a 37.7%…
NamSys Inc. Company Profile: NamSys Ticker: CTZ.V (TSXV) NMYSF (PNK)Website: NamSys.comShare Price: $1.09Market Cap: $29.7 million Shares Outstanding: 27.3 millionOptions and Warrants: NoneCash and Short Term Investments: $4.4 million Debt:…
Something I have been paying a lot more attention to is microcap executive compensation. I believe there is a correlation between executive compensation and shareholder return. My opinion is based…
For Part 1 of my Crescita analysis (CTX.TO, CRRTF) please read the previous post. I own shares of CTX.TO. Crescita Therapeutics (CTX.TO, CRRTF) is a publicly-traded, Canadian commercial dermatology company…
Crescita Therapeutics (TSX: CTX) is a publicly-traded, Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions…
In the world of microcap investing it is not always easy to find relevant information. Luckily I found the Planet MicroCap Podcast. There is a ton of information out there…